The p38 MAP kinase pathway and its biological function

Trends in Cardiovascular Medicine

Volumn 8, Issue 5, 1998, Pages 220-228

  New, Liguo ^a   Han, Jiahuai ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL GROWTH; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031817208     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00012-7     Document Type: Article

References (95)

1. Adolph EA, Subramaniam A, Cserjesi P, Olson EN, Robbins J: 1993. Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation the alpha-cardiac myosin heavy chain gene. J Biol Chem 268:5349-5352.
2. Anversa P, Beghi C, Kikkawa Y, Olivetti G: 1986. Myocardial infarction in rats: infarct size, myocyte hypertrophy, and capillary growth. Circ Res 58:26-37.
3. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE: 1996. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461.
4. Bagrodia S, Derijard B, Davis RJ, Cerione RA: 1995. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J Biol Chem 270:27,995-27,998.
5. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D: 1994. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev 8:453-464.
6. Beyaert R, Cuenda A, Vanden Berghe W, et al.: 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-1923.
7. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, et al.: 1996. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/ RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79:162-173.
8. Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC: 1993. An osmosensing signal transduction pathway in yeast. Science 259:1760-1763.
9. Cano E, Mahadevan L: 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20:117-121.
10. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM: 1997. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 272:15,023-15,027.
11. Crews CM, Alessandrini A, Erikson RL: 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258:478-480.
12. Cuenda A, Rouse J, Doza YN, et al.: 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
13. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M: 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16:295-305.
14. Derijard B, Raingeaud J, Barrett T, et al.: 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
15. El Benna J, Han J, Park JW, Schmid E, Ulevitch RJ, Babior BM: 1996. Activation of p38 in stimulated human neutrophils: phosphorylation off the oxidase component p47phox by p38 and ERK but not by JNK. Arch Biochem Biophys 334:395-400.
16. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC: 1996. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315:335-342.
17. Fan G, Merritt SE, Kortenjann M, Shaw PE, Holzman LB: 1996. Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapkk but not ERK2. J Biol Chem 271:24,788-24,793.
18. Fliss H, Gattinger D: 1996. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79:949-956.
19. Foltz IN, Lee JC, Young PR, Schrader JW: 1997. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272:3296-3301.
20. Freshney NW, Rawlinson L, Guesdon F, et al.: 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039-1049.
21. Fukunaga R, Hunter T: 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921-1933.
22. Geng Y, Valbracht J, Lotz M: 1996. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 98:2425-2430.
23. Goedert M, Hasegawa J, Craxton M, Leversha MA, Clegg S: 1997. Assignment of the human stress-activated protein kinase-3 gene (SAPK3) to chromosome 22q13.3 by fluorescence in situ hybridization. Genomics 41:501-502.
24. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J: 1997. Regulation of actin filament dynamics by p38 MAP kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110:357-368.
25. Hambleton J, Weinstein SL, Lem L, DeFranco AL: 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 93:2774-2778.
26. Han J, Lee JD, Tobias PS, and Ulevitch RJ: 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268:25009-25014.
27. Han J, Lee JD, Bibbs L, Ulevitch RJ: 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
28. Han J, Lee J-D, Jiang Y, Li Z, Feng L, and Ulevitch RJ: 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271:2886-2891.
29. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ: 1997a. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299.
30. Han J, Wang X, Jiang Y, Ulevitch RJ, Lin S: 1997b. Identification and characterization of a predominant isoform of human MKK3. FEBS Lett 403:19-22.
31. Hanks SK, Hunter T: 1995. The eukaryotic protein kinase superfamily: kinase (catalytic) domain strucutre and classification. FASEBJ 9:576-596.
32. Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahadevan LC: 1996. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr Biol 6: 1028-1031.
33. Heidenreich KA, Kummer JL: 1996. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 271:9891-9894.
34. Huang CK, Zhan L, Ai Y, Jongstra J: 1997. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J Biol Chem 272:17-19.
35. Huang S, Jiang Y, Li Z, et al.: 1997. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6:739-749.
36. Huot J, Houle F, Marceau F, Landry J: 1997. Oxidative stress-induced actin reorganization mediated by the p388 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80:383-392.
37. Ichijo H, Nishida E, Irie K, et al.: 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94.
38. Iordanov M, Bender K, Ade T, et al.: 1997. CREB is activated by UVC through a p38/ HOG-1-dependent protein kinase. EMBO J 16:1009-1022.
39. Janknecht R, Hunter T: 1997. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J 16:1620-1627.
40. Jiang Y, Chen C, Li Z, et al.: 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem 271:17,920-17,926.
41. Jiang Y, Gram H, Zhao M, et al.: 1997a. Characterization of the structure and function of the fourth member of p38 group MAP kinase-p38δ. J Biol Chem 272:30,122-30,128.
42. Jiang Y, Li Z, Schwarz EM, et al.: 1997b. Structure-function studies of p38 mitogen-activated protein kinase: loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J Biol Chem 272:11,096-11,102.
43. Juo P, Kuo CJ, Reynolds SE, et al.: 1997. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family protease. Mol Cell Biol 17:24-35.
44. Karin M, Hunter T: 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5:747-757.
45. Kawakami Y, Miura T, Bissonnette R, et al.: 1997. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 94:3938-3942.
46. Krump E, Sanghera JS, Pelech SL, Furuya W, Grinstein S: 1997. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J Biol Chem 272:937-944.
47. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR: 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533-538.
48. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J: 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20,608-20,616.
49. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A: 1996. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sc USA 93:4355-4359.
50. Lee JC, Laydon JT, McDonnell PC, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
51. Li Z, Jiang Y, Ulevitch RJ, Han J: 1996. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228:334-340.
52. Lin A, Minden A, Martinetto H, et al. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268:286-290.
53. Ludwig S, Engel K, Hoffmeyer A, et al. 1996. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. MolCell Biol 16:6687-6697.
54. McLaughlin MM, Kumar S, McDonnell PC, et al.: 1996. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 271:8488-8492.
55. Meier R, Rouse J, Cuenda A, Nebreda AR, Cohen P: 1996. Cellular stresses and cytokines activate multiple mitogen activated-protein kinase kinase homologues in PC12 and KB cells. Eur J Biochem 236:796-805.
56. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE: 1996. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sc USA 93:12,908-12,913.
57. Molnar A, Theodoras AM, Zon LI, Kyriakis JM: 1997. Cdc42Hs, but not Rac1 inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/ RK. J Biol Chem 272:13,229-13,235.
58. 2. J Biol Chem 271:26,981-26,988.
59. Muda M, Theodosiou A, Rodrigues N, et al.: 1996. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271:27,205-27,208.
60. Nagata Y, Moriguchi T, Nishida E, Todokoro K: 1997. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 90:929-934.
61. Nishina H, Fischer KD, Radvanyi L, et al.: 1997. Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385:350-353.
62. Pav S, White DM, Rogers S, et al.: 1997. Crystallization and preliminary crystallographic analysis off recombinant human P38 MAP kinase. Protein Sci 6:242-245.
63. Perregaux DG, Dean D, Cronan M, Connelly P, Gabel CA: 1995. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol 48:433-442.
64. Pietersma A, Tilly BC, Gaestel M, et al.: 1997. p38 mitogen activated protein kinase regulates endothelial VCAM-11 expression at the post-transcriptional level. Biochem Biophys Res Commun 230:44-48.
65. Price MA, Cruzalegui FH, Treisman R: 1996. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J 15:6552-6563.
66. Raingeaud J, Gupta S, Rogers JS, et al.: 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
67. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247-1255.
68. Rouse J, Cohen P, Trigon S, et al.: 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
69. Saklatvala J, Rawlinson L, Waller RJ, et al.: 1996. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 271:6586-6589.
70. Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL: 1996. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol 156:4457-4465.
71. Schwenger P, Bellosta P, Victor I, Basilico C, Skolnik EY, Vilcek J: 1997. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869-2873.
72. Shiozaki K, Russell P: 1995. Cell-cycle control linked to extracellular environment by MAP kinase pathway in fission yeast. Nature 378:739-743.
73. Shiozaki K, Russell P: 1996. Conjugation, meiosis, and the osmotic stress response are regulated by Spcl kinase through Atf1 transcription factor in fission yeast. Genes Dev 10:2276-2288.
74. Stokoe D, Campbell DG, Nakielny S, et al.: 1992. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J 11:3985-3994.
75. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ: 1996. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 15:4629-4642.
76. Tibbles LA, Ing YL, Kiefer F, et al.: 1996. MLK-3 activates the SAPK/JNK and p38/ RK pathways via SEK1 and MKK3/6. EMBO J 15:7026-7035.
77. Tilly BC, Gaestel M, Engel K, Edixhoven MJ, de Jonge HR: 1996. Hypo-osmotic cell swelling activates the p38 MAP kinase signaling cascade. FEBS Lett 395:133-136.
78. Tong L, Pav S, White DM, et al.: 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATPP pocket. Nat Struct Biol 4:311-316.
79. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ: 1997. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc Natl Acad Sci USA 94:7337-7342.
80. Treisman R. 1996. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8:205-215.
81. Wang XS, Diener K, Jannuzzi D, et al.: 1996. Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase. J Biol Chem 271:31607-31611.
82. Wang XZ, Ron D: 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 272:1347-1349.
83. Wang Y, Huang S, Sah V, et al.: 1998. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of p38 mitogen-activated protein kinase family. J Biol Chem 273:2161-2168.
84. Wang Z, Harkins PC, Ulevitch RJ, Han J, Cobb MH, Goldsmith EJ: 1997. The structure of mitogen-activated protein kinase p38 at 2.1-AA resolution. Proc Natl Acad Sci USA 94:2327-2332.
85. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA: 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16:1909-1920.
86. Weinbrenner C, Liu GS, Cohen MV, Downey JM: 1997. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29:2383-2391.
87. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, Davis RJ: 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17:2360-2371.
88. Wilson KP, Fitzgibbon MJ, Caron PR, et al.: 1996. Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 271: 27,696-27,700.
89. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
90. Yan M, Dai T, Deak JC, et al.: 1994. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372:798-800.
91. Yin T, Sandhu G, Wolfgang CD, et al.: 1997. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272:19,943-19,950.
92. Yuo A, Okuma E, Kitagawa S, Takaku F: 1997. Tyrosine phosphorylation of p38 but not extracellular signal-regulated kinase in normal human neutrophils stimulated by tumor necrosis factor: comparative study with granulocyte-macrophage colony-stimulating factor. Biochem Biophys Res Commun 235:42-46.
93. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC: 1997. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139: 115-127.
94. Zhang S, Han J, Sells MA, et al.: 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270: 23,934-23,936.
95. Zhu H, Nguyen VT, Brown AB, et al.: 1993. A novel, tissue-restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF2) in the rat myosin light-chain 2 gene. Mol Cell Biol 13:4432-4444.